Press Releases
Resilience Establishes Multi-Product Development and Manufacturing Collaboration with Takeda’s Plasma-Derived Therapies Business Unit
National Resilience, Inc. (Resilience), a technology-focused manufacturing company dedicated to broadening access to complex medicines, announced a manufacturing services agreement with Takeda’s Plasma-Derived Therapies...
Clinical Trials
Tesis Biosciences Acquires Genome Explorations to Accelerate Clinical Research and Product Development for Chronic Disease Cures
Tesis Biosciences, the leader in targeted genetic sequencing, has acquired Genome Explorations, a premier research institution providing global genomic profiling and molecular diagnostics services.
The...
Clinical Trials
Velocity Clinical Research makes tech investments to strengthen patient and client engagement in clinical trials
Velocity Clinical Research, the largest fully integrated clinical site organization, announces three key tech investments to expand its patient community, increase client engagement, and...
News
Pfizer Jab For Kids Under Five May Not Be Out Soon Says FDA
In a recent development, which is a kind of a setback in the case of inoculation for kids, the FDA has confirmed that it...
Press Releases
PHARMINTECH and IPACK-IMA: a synergic union
The 7thedition of Pharmintech Exhibition is goingto take place in Milan from May 3 to 6, 2022 in conjunction with IPACK-IMA, the most important...
News
WHO prequalifies first monoclonal antibody – tocilizumab – to treat COVID-19
Aiming to increase access to recommended treatments for COVID-19, WHO today added tocilizumab, a monoclonal antibody, to its list of prequalified treatments for COVID-19....
Press Releases
Glenmark inks agreement with AstraZeneca to commercialize its product Pulmicort Respules in Colombia
Glenmark Pharmaceuticals, an innovation–driven, global pharmaceutical company, announced that its subsidiary Glenmark Pharmaceuticals Colombia S.A.S. and AstraZeneca Colombia S.A.S. have entered into an exclusive...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read